Timothé CYNOBER (Pharm D.)
Paris, Île-de-France, France
6 k abonnés
+ de 500 relations
À propos
Pharm D passionate about pioneering innovations that transform patient care and empower…
Articles de Timothé
-
5 WAYS PHARMA CAN BENEFIT FROM THE METAVERSE
5 WAYS PHARMA CAN BENEFIT FROM THE METAVERSE
This article is a collaboration between Timothé Cynober and Anca Petre. Reinvent the way pharma industries are…
4 commentaires
Activité
-
[#BIO2025] Techbio- part 2! Discover the Techbio companies that will be showcasing their solutions at the French Pavillion. NETRI offers a…
[#BIO2025] Techbio- part 2! Discover the Techbio companies that will be showcasing their solutions at the French Pavillion. NETRI offers a…
Aimé par Timothé CYNOBER (Pharm D.)
-
📣 We are both proud and excited to announce that Astraveus has entered into a strategic partnership with NecstGen to evaluate the Lakhesys Benchtop…
📣 We are both proud and excited to announce that Astraveus has entered into a strategic partnership with NecstGen to evaluate the Lakhesys Benchtop…
Aimé par Timothé CYNOBER (Pharm D.)
-
To be or not to be torn between two, maybe even three, business models: Schrödinger Interesting moves at Schrödinger at a time when they continue…
To be or not to be torn between two, maybe even three, business models: Schrödinger Interesting moves at Schrödinger at a time when they continue…
Aimé par Timothé CYNOBER (Pharm D.)
Expérience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Formation
-
Université Paris-Saclay
-
Activités et associations :Creation of website (www.master-biotech.u-psud.fr/)
Regulatory affairs (CT and CMC for biologics, Study case on Biosimilar)
Research and development (Monoclonal antibodies, Cell therapy, Gene therapy…)
Production and bioprocessing of recombinant protein
Quality assurance (Education and practical works) -
-
www.adngroup.com
-
-
2 weeks certificate BD&L for software
IP - Copyrights & Patents
Tech Transfer & Licensing
-
-
Pharm D. Exercise Thesis with distinction: Challenges and opportunities including market and regulatory landscape for an active natural substance.
-
-
Expériences de bénévolat
-
Hello Tomorrow Challenge - Life Sciences & Deep-tech Challenge - Curator and Jury - Life Sciences & Deep-tech
Hello Tomorrow
- 2 ans 1 mois
Santé
Hello Tomorrow is an international non-profit which aims to empower deep-tech entrepreneurs to help them take their innovation to market.
Publications
-
Could Stem Cells eventually replace Animal Testing in Drug Development?
Labiotech
Voir la publicationAnimal testing is a crucial part of developing new medicines, but it is accompanied by a host of ethical concerns. Stem cell models could eventually make it unnecessary.
-
Why are there only 8 cell and gene therapies on the EU Market?
Labiotech
Voir la publicationIf you are following Labiotech, you’ll have noticed that there is frequent news about exciting ATMPs (cell or genes therapies) under development. But why have only a few of them reached the market?
-
Stem Cell Tourism makes Big Promises but may End your Life…
Labiotech
Voir la publicationDesperate patients are ready to do everything to access to new treatments and Google searches can help them find medicines in the early stages of development rather than those with proper authorization. They latch on to this false hope and travel to search for treatments, sometimes with deadly consequences.
-
1H qNMR quantification of Annonaceous acetogenins in crude extracts of Annona muricata L. fruit pulp.
Phytochemical Analysis
1H qNMR quantification of Annonaceous acetogenins in crude extracts of Annona muricata L. fruit pulp.
Autres auteurs -
Langues
-
Anglais
Capacité professionnelle complète
-
German
Notions
-
French
Bilingue ou langue natale
Recommandations reçues
3 personnes ont recommandé Timothé
Inscrivez-vous pour y accéderPlus d’activités de Timothé
-
👋 I am hiring a Senior Product Manager in my team to manage Rank Math WordPress plugin: https://rankmath.com/ We are looking for a Senior PM who's…
👋 I am hiring a Senior Product Manager in my team to manage Rank Math WordPress plugin: https://rankmath.com/ We are looking for a Senior PM who's…
Aimé par Timothé CYNOBER (Pharm D.)
-
Today, Hélène and I co-chaired a session on cellular immunotherapies at the international conference on Innovations for Cell and Gene Therapies…
Today, Hélène and I co-chaired a session on cellular immunotherapies at the international conference on Innovations for Cell and Gene Therapies…
Aimé par Timothé CYNOBER (Pharm D.)
-
Si fier de voir les résultats de notre travail quotidien au développement de nos écosystèmes de #startups. 🚀 🇫🇷 🇪🇺 NVIDIA for Startups Startup…
Si fier de voir les résultats de notre travail quotidien au développement de nos écosystèmes de #startups. 🚀 🇫🇷 🇪🇺 NVIDIA for Startups Startup…
Aimé par Timothé CYNOBER (Pharm D.)
-
BiotechFinances n° 1115 est en ligne. On parle de : JEITO et de ReproNovo avec Ksenija Pavletic, d'iktos, de ReST THERAPEUTICS, d'InBrain Pharma…
BiotechFinances n° 1115 est en ligne. On parle de : JEITO et de ReproNovo avec Ksenija Pavletic, d'iktos, de ReST THERAPEUTICS, d'InBrain Pharma…
Aimé par Timothé CYNOBER (Pharm D.)
-
💡 The Omnes’ Spring 2025 Scope Report features an interview with our CEO, David Del Bourgo, on how WhiteLab is driving breakthroughs in genomic…
💡 The Omnes’ Spring 2025 Scope Report features an interview with our CEO, David Del Bourgo, on how WhiteLab is driving breakthroughs in genomic…
Aimé par Timothé CYNOBER (Pharm D.)
-
🚀 Levée de fonds exceptionnelle pour SeqOne : 20 M€ pour révolutionner la médecine de précision Félicitations à SeqOne, membre de l’écosystème…
🚀 Levée de fonds exceptionnelle pour SeqOne : 20 M€ pour révolutionner la médecine de précision Félicitations à SeqOne, membre de l’écosystème…
Aimé par Timothé CYNOBER (Pharm D.)
-
The quiet undercurrent at ASGCT this year? Gene therapy doesn't need more hype. It needs validation: Because despite the recent doom and gloom…
The quiet undercurrent at ASGCT this year? Gene therapy doesn't need more hype. It needs validation: Because despite the recent doom and gloom…
Aimé par Timothé CYNOBER (Pharm D.)
-
Join us on June 3rd for our #NYTechWeek fireside chat where NVIDIA's Director of Digital Biology Anthony Costa and Dyno Therapeutics CEO & Cofounder…
Join us on June 3rd for our #NYTechWeek fireside chat where NVIDIA's Director of Digital Biology Anthony Costa and Dyno Therapeutics CEO & Cofounder…
Aimé par Timothé CYNOBER (Pharm D.)
-
If you work in gene delivery, save this one for later. One of the best overviews I've come across. But one particular thing stands out for…
If you work in gene delivery, save this one for later. One of the best overviews I've come across. But one particular thing stands out for…
Aimé par Timothé CYNOBER (Pharm D.)
-
🎬 Nous avons eu l’honneur de recevoir Jane Fonda à l’Institut Curie ! 🏆 Lauréate du Marie Curie Legacy Award 2024 remis à New York en novembre…
🎬 Nous avons eu l’honneur de recevoir Jane Fonda à l’Institut Curie ! 🏆 Lauréate du Marie Curie Legacy Award 2024 remis à New York en novembre…
Aimé par Timothé CYNOBER (Pharm D.)
-
🇫🇷 Paris dans le Top 5, je m'en réjouis comme tout l'écosystème #FrenchTech en ce moment ! Bravo à tous 👏 Mais comment faire pour que la valeur…
🇫🇷 Paris dans le Top 5, je m'en réjouis comme tout l'écosystème #FrenchTech en ce moment ! Bravo à tous 👏 Mais comment faire pour que la valeur…
Aimé par Timothé CYNOBER (Pharm D.)